Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers

Neoplasma

Volumn 45, Issue 5, 1998, Pages 312-317

  Salagovic J ^a   Kalina, I ^a,b   Stubna J ^b   Habalova V ^a   Hrivnak M ^b   Valansky L ^b   Kohut A ^a   Biros E ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Teaching Hospital   (Slovakia)

Author keywords

Cancer risk; Genetic polymorphism; Glutathione S transferases M1 and T1; Lung and bladder cancers; Susceptibility

Indexed keywords

GLUTATHIONE TRANSFERASE; ISOENZYME;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; SMOKING;

EID: 0032406860     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. ARAND, M., MUHLBAUER, R., HENGSTLER, J., JAGER, E., FUCHS, J., WINKLER, L., OESCH, F.: A multiplex polymerase chain reac-tion protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem., 236, 1996, 184-186.
2. BARTSCH, H., HIETANEN, E.: The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Persp., 104, 1996, 569-577.
3. BELL, D.A., TAYLOR, J.A., PAULSON, D.F., ROBERTSON, C. N., MOHLER, J.L., LUCIER, G.W.: Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85, 1993, 1159-1164.
4. BROCKMÖLLER, J., KERB, R., DRAKUOLIS, N., NITZ, M., ROOTS, I.: Genotype and phenotype of glutathione S-transferase class μ isoenzymes in lung cancer patients and controls. Cancer Res., 53, 1993, 1004-1011.
5. BROCKMÖLLER, J., CASCORBI, I., KERB, R., ROOTS, I.: Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutahione S-transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56, 1996, 3915-3925.
6. DOLL, R., PETO, R.: The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1981, 1191-1308.
7. HOFFMAN, D., HECHT, S.S.: Advances in tobacco carcinogenesis. In: Handbook of Experimental Pharmacology, Vol. 94/1. Eds: Cooper, C.S., Grover, P.L. Heidelberg, Springer-Verlag 1990, 63-102.
8. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 38. Tobacco Smoking. Lyon, IARC 1986, 244-270.
9. IARC Monographs on the evaluation of the carcinogenic risks to humans. Supplement 7. Overall evaluations of carcinogenicity: An updating of IARC monograph volumes 1 to 42. Lyon, IARC 1987, 106-116.
10. KEMPKES, M., GOLKA, K., REICH, S., RECKWITZ, T., BOLT, H.M.: Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factor for urothelial cancer of the bladder. Arch. Toxicol., 71, 1996, 123-126.
11. KETTERER, B., HARRIS, J.M., TALASKA, G., MEYER, D.J., PEMBLE, S.E., TAYLOR, J.B., LANG, N.P., KADLUBAR, F.F.: The human glutahione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Persp., 98, 1992, 87.